Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 5, 2015, Pages 438-448

  Camilleri, M ^a   Acosta, A ^a   Busciglio, I ^a   Boldingh, A ^a   Dyer, R B ^b   Zinsmeister, A R ^b   Lueke, A ^b   Gray, A ^b   Donato, L J ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA HYDROXY 4 CHOLESTEN 3 ONE; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLESTEROL DERIVATIVE; CHOLIC ACID; COLESEVELAM; DEOXYCHOLIC ACID; FECES BILE ACID; FECES LIPID; LITHOCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; 7 ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; ALLYLAMINE; CHOLEST 4 EN 3 ONE; GASTROINTESTINAL AGENT;

ACCURACY; ADULT; AGED; ARTICLE; BILE ACID SYNTHESIS; BILIARY EXCRETION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DEFECATION; DIARRHEA; DRUG ACTIVITY; DRUG BINDING; DRUG RESPONSE; FECES; FECES ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRRITABLE COLON; MALE; SINGLE DRUG DOSE; STEATORRHEA; TABLET; ANALOGS AND DERIVATIVES; BLOOD; IRRITABLE BOWEL SYNDROME; METABOLISM; MIDDLE AGED;

ADULT; ALLYLAMINE; BILE ACIDS AND SALTS; CHOLESTENONES; DEOXYCHOLIC ACID; DIARRHEA; FECES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IRRITABLE BOWEL SYNDROME; MIDDLE AGED;

EID: 84921842684     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13065     Document Type: Article

References (27)

1. Camilleri M, McKinzie S, Busciglio I, et al,. Prospective study of motor, sensory, psychological and autonomic functions in 119 patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 772-81.
2. Wedlake L, A'Hern R, Russell D, et al,. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30: 707-17.
3. Wong BS, Camilleri M, Carlson P, et al,. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012; 10: 1009-15.
4. Shin A, Camilleri M, Vijayvargiya P, et al,. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 1270-5.
5. Poole DP, Godfrey C, Cattaruzza F, et al,. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil 2010; 22: 814-25.
6. Alemi F, Poole DP, Chiu J, et al,. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 2013; 144: 145-54.
7. Vijayvargiya P, Camilleri M, Shin A, et al,. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 2013; 11: 1232-9.
8. Stotzer P-O, Abrahamsson H, Bajor A, Sadik R,. Effect of cholestyramine on gastrointestinal transit in patients with idiopathic bile acid diarrhea: a prospective, open-label study. Neuroenterology 2013; 2: 5. doi: 10.4303/ne/235657 Article ID 235657.
9. Bajor A, Törnblom H, Rudling M, et al,. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut 2015; 64: 84-92.
10. Eriksson M, Hådell K, Holme I, et al,. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med 1998; 243: 373-80.
11. Bays HE, Maki KC, Schmitz K,. Colesevelam hydrochloride powder for oral suspension versus cholestyramine powder for oral suspension: comparison of acceptability and tolerability. Endocr Pract 2011; 17: 218-25.
12. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al,. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010; 8: 159-65.
13. Talley NJ, Phillips SF, Wiltgen CM, et al,. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
14. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
15. Heaton KW, Radvan J, Cripps H, et al,. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992; 33: 818-24.
16. Andresen V, Camilleri M, Busciglio I, et al,. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology 2007; 133: 761-8.
17. Manini ML, Camilleri M, Goldberg M, et al,. Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil 2010; 22: e7-8.
18. Sauter GH, Münzing W, von Ritter C, et al,. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci 1999; 44: 14-9.
19. Brydon WG, Nyhlin H, Eastwood MA, et al,. Serum 7 alpha-hydroxy-4-cholesten-3-one and seleno-homocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 1996; 8: 117-23.
20. Gälman C, Arvidsson I, Angelin B, et al,. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res 2003; 44: 859-66.
21. Camilleri M, Nadeau A, Tremaine WJ, et al,. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009; 21: 734-e43.
22. Tagliacozzi D, Mozzi AF, Casetta B, et al,. Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin Chem Lab Med 2003; 41: 1633-41.
23. Lin LI-K,. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-68.
24. Camilleri M, Busciglio I, Acosta A, et al,. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol 2014; 109: 1621-30.
25. Pattni SS, Brydon WG, Dew T, et al,. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 2013; 38: 967-76.
26. Mitchell WD, Findlay JM, Prescott RJ, et al,. Bile acids in the diarrhoea of ileal resection. Gut 1973; 14: 348-53.
27. Wilcox C, Turner J, Green J,. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther 2014; 39: 923-39.